Singapore markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.51-0.11 (-1.44%)
At close: 04:00PM EST
7.62 +0.11 (+1.46%)
After hours: 04:49PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
155,270
33,215
34,505
28,267
Operating expenses
Research development
130,006
90,570
80,141
95,955
Selling general and administrative
59,350
30,775
24,748
32,596
Total operating expenses
188,229
121,345
104,889
128,551
Operating income or loss
-32,959
-88,130
-70,384
-100,284
Interest expense
2,931
2,924
502
-
Total other income/expenses net
-937
981
-426
170
Income before tax
-33,829
-89,127
-70,279
-98,942
Income from continuing operations
-33,829
-89,127
-70,279
-98,942
Net income
-33,829
-89,127
-70,279
-98,942
Net income available to common shareholders
-33,829
-89,127
-70,279
-98,942
Basic EPS
-
-1.12
-1.24
-2.43
Diluted EPS
-
-1.12
-1.24
-2.43
Basic average shares
-
79,789
56,649
40,743
Diluted average shares
-
79,789
56,649
40,743
EBITDA
-
-79,625
-62,174
-92,422